IFNA2: A Potential Drug Target and Biomarker (G3440)

Target Name: IFNA2

NCBI ID: G3440

IFNA2: A Potential Drug Target and Biomarker

IFNA2 (Interferon-alpha-2) is a protein that is expressed in various tissues throughout the body, including the liver, spleen, and peripheral blood cells. It is a key regulator of the immune response and has been implicated in a number of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. In this article, we will explore the potential implications of IFNA2 as a drug target and potential biomarker.

IFNA2 as a Drug Target

IFNA2 has been identified as a potential drug target due to its involvement in the immune response and its association with a number of diseases. One of the key mechanisms by which IFNA2 is involved in the immune response is its role as a signaling molecule for T cells. T cells are a critical part of the immune system and play a crucial role in protecting the body against infection and disease. IFNA2 has been shown to regulate the development and function of T cells, including their activation, proliferation, and differentiation.

In addition to its role in T cell regulation, IFNA2 has also been shown to play a key role in the regulation of inflammation. Chronic inflammation is associated with a number of diseases, including heart disease, diabetes, and neurodegenerative disorders. IFNA2 has been shown to regulate the production of pro-inflammatory cytokines, such as TNF-alpha, and to have anti-inflammatory effects. This suggests that IFNA2 may be a useful target for the treatment of chronic inflammatory diseases.

IFNA2 as a Biomarker

IFNA2 has also been shown to be a potential biomarker for a number of diseases. In cancer, IFNA2 has been shown to be overexpressed in a number of tumors and to be associated with poor prognosis. In addition, IFNA2 has been shown to be involved in the development of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. These findings suggest that IFNA2 may be a useful biomarker for the diagnosis and treatment of these disorders.

IFNA2 Targets

IFNA2 has been shown to interact with a number of different proteins, including the transcription factor NF-kappa-B. NF-kappa-B is a key regulator of inflammation and has been implicated in a number of diseases, including cancer and neurodegenerative disorders. IFNA2 has been shown to regulate the activity of NF-kappa-B and to play a role in the regulation of inflammation.

IFNA2 Interactions with Other Proteins

IFNA2 has also been shown to interact with a number of other proteins, including the transcription factor SMAD3. SMAD3 is a key regulator of cell growth and is involved in the regulation of gene expression. IFNA2 has been shown to regulate the activity of SMAD3 and to play a role in the regulation of cell growth.

IFNA2 Interactions with Enzymes

IFNA2 has also been shown to interact with a number of enzymes, including the enzyme tyrosine aminotransferase (TAT). TAT is an enzyme that is involved in the metabolism of neurotransmitters, including dopamine and serotonin. IFNA2 has been shown to regulate the activity of TAT and to play a role in the regulation of neurotransmitter metabolism.

Conclusion

In conclusion, IFNA2 is a protein that has been shown to play a number of important roles in the immune and inflammatory responses. Its involvement in T cell regulation, inflammation, and neurodegenerative diseases makes it a potential drug target and biomarker. Further research is needed to fully understand the role of IFNA2 in these processes and to develop effective treatments for the associated diseases.

Protein Name: Interferon Alpha 2

Functions: Produced by macrophages, IFN-alpha have antiviral activities

More Common Targets